Editorial: Adenylyl cyclase isoforms as potential drug targets
Front Pharmacol
.
2022 Dec 9:13:1098240.
doi: 10.3389/fphar.2022.1098240.
eCollection 2022.
Authors
Tarsis F Brust
1
2
,
Rennolds S Ostrom
3
,
Val J Watts
4
Affiliations
1
Department of Pharmaceutical Sciences, Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, FL, United States.
2
ATyr Pharma, San Diego, CA, United States.
3
Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, CA, United States.
4
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, United States.
PMID:
36569292
PMCID:
PMC9780657
DOI:
10.3389/fphar.2022.1098240
No abstract available
Keywords:
G protein; adenylate cyclase; adenylyl cyclase; cAMP; cell signaling.
Publication types
Editorial
Grants and funding
R01 GM107094/GM/NIGMS NIH HHS/United States